Hilltop Bio provides regenerative therapies helping injured horses regenerate damaged tissues and assist in restoring them.
Hilltop BioSciences has raised $5.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2024.
Hilltop BioSciences's investors include LaunchPad Venture, Mid Atlantic Bio Angels, Sidecar Angels, Sky Ventures Group.
Hilltop BioSciences is headquartered in Mansfield, United States.
Hilltop Bio provides regenerative therapies helping injured horses regenerate damaged tissues and assist in restoring them.
Hilltop BioSciences is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hilltop BioSciences — Funding & Investors." VCBacked, December 12, 2024, https://www.vcbacked.co/company/hilltop-biosciences. Accessed August 14, 2026.
VCBacked. (2024). Hilltop BioSciences — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/hilltop-biosciences
{{cite web |title=Hilltop BioSciences — Funding & Investors |url=https://www.vcbacked.co/company/hilltop-biosciences |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated